Jorey Chernett, a major shareholder of CVRx, has called on the company's board to start a formal sale process to a strategic buyer. He argues that CVRx's Barostim product is highly valuable to large medical device companies and that a sale would provide shareholders with immediate and superior returns compared to continuing independently. Chernett also urges cost cuts and a clear timeline for the sale process to maximize value while the company still has cash and market momentum. The move aims to avoid a weaker position if delayed until cash runs low.
TD Cowen raised its forecast for Amazon's AWS revenue to $165 billion by 2026, citing strong growth fueled by AI adoption and a $200 billion capital expenditure plan focused on AI infrastructure. AWS is growing rapidly, with a 24% year-over-year incr...
Nebius Group's stock fell 21.09% after reporting a 454% revenue surge in Q2 driven by its AI cloud segment. Despite strong demand and multi-year revenue visibility with $37.49 billion in remaining obligations, the company faces significant risks from...
DiagnaMed Holdings Corp. has appointed Charles Turmel, an energy law specialist, to its Board of Directors to support its strategic focus on natural clean hydrogen exploration. The company is advancing projects in Ontario and Nova Scotia, including t...
Collins Aerospace has successfully completed altitude testing of its Enhanced Power and Cooling System (EPACS), designed to improve the F-35 fighter jet's power and thermal management. This next-generation system provides significantly increased cool...
Socket Mobile and Orda have partnered to deploy a mobile ordering and self-checkout solution in workplace dining environments, starting in New York City. This collaboration combines Orda's mobile ordering platform with Socket Mobile's S320 Contactles...
